Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3507129016 | Dapoxetine hydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3507130014 | Dapoxetine hydrochloride | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dapoxetine hydrochloride | Is a | Dapoxetine | false | Inferred relationship | Existential restriction modifier | ||
| Dapoxetine hydrochloride | Has disposition | Serotonin reuptake inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Dapoxetine hydrochloride | Is a | Substance with serotonin re-uptake inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Dapoxetine hydrochloride | Is a | Naphthalene | true | Inferred relationship | Existential restriction modifier | ||
| Dapoxetine hydrochloride | Is modification of | Dapoxetine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dapoxetine (as dapoxetine hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dapoxetine hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
| Product containing precisely dapoxetine (as dapoxetine hydrochloride) 60 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Dapoxetine hydrochloride | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR